Regulation & law · 04/11/1996

National Cancer Institute Seeks Pharmaceutical or Biotechnology Partner for B-Cell Lymphoma Research

The National Cancer Institute is seeking a cooperative research and development agreement with a pharmaceutical or biotechnology company to develop strategies for isolating B-cell lymphoma tumor specific antigen, with the goal of rapid publication of research results and timely commercialization of resulting products.